ISLAND PHARMACEUTICALS LTD
Clinical trial NCT06439953 updates: 1. completion date: 2026-09-30 → 2028-04-01 2. primary completion date: 2026-09-30 → 2028-04-01
Clinical trial NCT06439953 updates: 1. completion date: 2026-09-30 → 2028-04-01 2. primary completion date: 2026-09-30 → 2028-04-01
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical